Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy

[1]  Somanath Padhi,et al.  Dyskeratosis Congenita. , 2019, Mayo Clinic proceedings.

[2]  J. de Villartay,et al.  Cernunnos/Xlf Deficiency Results in Suboptimal V(D)J Recombination and Impaired Lymphoid Development in Mice , 2019, Front. Immunol..

[3]  W. Chng,et al.  Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas , 2016, Proceedings of the National Academy of Sciences.

[4]  M. Fullwood,et al.  Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation. , 2016, Cancer discovery.

[5]  Y. Loh,et al.  Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression. , 2016, The Journal of clinical investigation.

[6]  S. Jackson,et al.  Specific Roles of XRCC4 Paralogs PAXX and XLF during V(D)J Recombination , 2016, Cell reports.

[7]  Yong Chen,et al.  TRF2-RAP1 is required to protect telomeres from engaging in homologous recombination-mediated deletions and fusions , 2016, Nature Communications.

[8]  M. van der Burg,et al.  DNA-PKcs Is Involved in Ig Class Switch Recombination in Human B Cells , 2015, The Journal of Immunology.

[9]  Fang-ping Chen,et al.  Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia. , 2015, Molecular medicine reports.

[10]  S. Leow,et al.  Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity. , 2015, The Journal of clinical investigation.

[11]  Ting-dong Yan,et al.  Quantitative assessment of telomerase components in cancer cell lines , 2015, FEBS letters.

[12]  T. Tan,et al.  Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects. , 2014, Cell reports.

[13]  C. Ramírez,et al.  Nontelomeric role for Rap1 in regulating metabolism and protecting against obesity. , 2013, Cell reports.

[14]  E. Mercken,et al.  RAP1 Protects from Obesity through Its Extratelomeric Role Regulating Gene Expression , 2013, Cell reports.

[15]  Mira Ayadi,et al.  Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value , 2013, PLoS medicine.

[16]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[17]  S. Snyder,et al.  Inositol Polyphosphate Multikinase Is a Coactivator of p53-Mediated Transcription and Cell Death , 2013, Science Signaling.

[18]  Kenichi Yoshida,et al.  Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells , 2013, Tumor Biology.

[19]  K. O'Byrne,et al.  Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy , 2013, Front. Oncol..

[20]  J. Griffith,et al.  Human Rap1 Interacts Directly with Telomeric DNA and Regulates TRF2 Localization at the Telomere* , 2012, The Journal of Biological Chemistry.

[21]  B. Tu,et al.  Mitochondrial localization of telomeric protein TIN2 links telomere regulation to metabolic control. , 2012, Molecular cell.

[22]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[23]  M. Salto‐Tellez,et al.  Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  M. Blasco,et al.  Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins , 2011, Nature Reviews Cancer.

[25]  J. Petrini,et al.  The MRE11 complex: starting from the ends , 2011, Nature Reviews Molecular Cell Biology.

[26]  D. Shore,et al.  A conserved motif within RAP1 has diversified roles in telomere protection and regulation in different organisms , 2011, Nature Structural &Molecular Biology.

[27]  Zhijian J. Chen,et al.  ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. , 2010, Molecular cell.

[28]  Sumit K. Chanda,et al.  Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression , 2010, Nature Cell Biology.

[29]  D. Pisano,et al.  Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites , 2010, Nature Cell Biology.

[30]  Laure Crabbe,et al.  Mammalian Rap1 widens its impact , 2010, Nature Cell Biology.

[31]  H. Yasaei,et al.  Defective Artemis causes mild telomere dysfunction , 2010, Genome Integrity.

[32]  E. Gilson,et al.  TRF2/RAP1 and DNA–PK mediate a double protection against joining at telomeric ends , 2010, The EMBO journal.

[33]  G. Celli,et al.  Loss of Rap1 Induces Telomere Recombination in the Absence of NHEJ or a DNA Damage Signal , 2010, Science.

[34]  T. Yeatman,et al.  Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. , 2010, Gastroenterology.

[35]  R. O'Sullivan,et al.  Telomeres: protecting chromosomes against genome instability , 2010, Nature Reviews Molecular Cell Biology.

[36]  P. Baumann,et al.  Human RAP1 inhibits non‐homologous end joining at telomeres , 2009, The EMBO journal.

[37]  Alberto Martin,et al.  Msh2-dependent DNA repair mitigates a unique susceptibility of B cell progenitors to c-Myc-induced lymphomas , 2009, Proceedings of the National Academy of Sciences.

[38]  S. Blackwood,et al.  In Vivo Stoichiometry of Shelterin Components* , 2009, The Journal of Biological Chemistry.

[39]  R. Tomar,et al.  Yeast Rap1 contributes to genomic integrity by activating DNA damage repair genes , 2008, The EMBO journal.

[40]  Jeremy M. Stark,et al.  Alternative-NHEJ Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break Repair , 2008, PLoS genetics.

[41]  Jiri Bartek,et al.  An Oncogene-Induced DNA Damage Model for Cancer Development , 2008, Science.

[42]  H. Stein,et al.  The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo. , 2007, Blood.

[43]  John Lough,et al.  Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response , 2007, Nature.

[44]  A. Seluanov,et al.  TRF2 is required for repair of nontelomeric DNA double-strand breaks by homologous recombination , 2007, Proceedings of the National Academy of Sciences.

[45]  J. Cleveland,et al.  Atm Deficiency Affects Both Apoptosis and Proliferation to Augment Myc-Induced Lymphomagenesis , 2007, Molecular Cancer Research.

[46]  B. A. Ballif,et al.  ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage , 2007, Science.

[47]  P. Baumann,et al.  A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends. , 2007, Molecular cell.

[48]  Howard Y. Chang,et al.  MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species. , 2006, Cancer research.

[49]  P. M. Nissom,et al.  A novel normalization method for effective removal of systematic variation in microarray data , 2006, Nucleic acids research.

[50]  John T. Powers,et al.  ATM promotes apoptosis and suppresses tumorigenesis in response to Myc , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Mina J Bissell,et al.  Higher-order nuclear organization in growth arrest of human mammary epithelial cells: a novel role for telomere-associated protein TIN2 , 2004, Journal of Cell Science.

[52]  J. Qin,et al.  Telosome, a Mammalian Telomere-associated Complex Formed by Multiple Telomeric Proteins* , 2004, Journal of Biological Chemistry.

[53]  Jun Qin,et al.  The Human Rap1 Protein Complex and Modulation of Telomere Length* , 2004, Journal of Biological Chemistry.

[54]  T. de Lange,et al.  Rap1 affects the length and heterogeneity of human telomeres. , 2003, Molecular biology of the cell.

[55]  Yingnian Yu,et al.  ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses. , 2003, Carcinogenesis.

[56]  G. Wahl,et al.  p53 stabilization is decreased upon NFκB activation , 2002 .

[57]  G. Wahl,et al.  c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. , 2002, Molecular cell.

[58]  S. Jackson,et al.  Sensing and repairing DNA double-strand breaks. , 2002, Carcinogenesis.

[59]  T. Lange,et al.  Identification of Human Rap1 Implications for Telomere Evolution , 2000, Cell.

[60]  Wen-Hwa Lee,et al.  Temporal, spatial, and cell type–specific control of Cre-mediated DNA recombination in transgenic mice , 1999, Nature Biotechnology.

[61]  S. Lowe,et al.  INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. , 1999, Genes & development.

[62]  D. Felsher,et al.  Transient excess of MYC activity can elicit genomic instability and tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Greene.  Linker‐Scanning Mutagenesis of DNA , 1991, Current protocols in molecular biology.

[64]  R. Palmiter,et al.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.

[65]  I. Dokal.  Dyskeratosis congenita. , 2011, Hematology. American Society of Hematology. Education Program.

[66]  G. Wahl,et al.  p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. , 2002, Cancer cell.